TFA Therapeutics RAJAF
OTC RAJAF
$9.18 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

TFA Therapeutics (RAJAF) Net Cash Flow (2020 - 2023)

TFA Therapeutics (RAJAF) posted Net Cash Flow of $8511.0 for Q4 2023, up 105.43% on a QoQ basis from -$156808.0 in Q4 2022, and up 105.43% year-over-year from $4143.1 in Q4 2022.

Analysis

TFA Therapeutics (RAJAF) Net Cash Flow (2020 - 2023) Analysis & Trends

TFA Therapeutics has reported Net Cash Flow for 3 years, with the latest figure at $8511.0 in Q4 2023.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Cash Flow (Qtr)
1 Colgate Palmolive 70.23 Bn 68.86 Bn 3.30 Bn 22.00 Mn
2 Kenvue 34.13 Bn 33.02 Bn 2.30 Bn 23.00 Mn
3 Kimberly Clark 32.73 Bn 31.77 Bn 1.60 Bn 803.00 Mn
4 Bath & Body Works 3.77 Bn 2.98 Bn 692.00 Mn -
5 Prestige Consumer Healthcare 2.27 Bn 2.21 Bn - -
6 Perrigo 1.89 Bn 1.49 Bn 313.90 Mn 43.10 Mn
7 Herbalife 1.28 Bn 905.45 Mn 1.03 Bn -71.40 Mn
8 Edgewell Personal Care 1.24 Bn 840.59 Mn 242.50 Mn 97.30 Mn
9 TFA Therapeutics 1.02 Bn 1.02 Bn - -
10 Honest Company 586.90 Mn 481.00 Mn 40.36 Mn 15.53 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 8,511.00
Dec 31, 2022 -156,808.00
Dec 31, 2020 279.00